U.S. Markets closed

Medtronic plc (MDT)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
84.61+0.62 (+0.74%)
At close: 4:01PM EDT

84.50 -0.11 (-0.13%)
After hours: 4:59PM EDT

People also watch
ABTBSXSTJSYKJNJ

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
http://www.medtronic.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees88,000

Key Executives

NameTitlePayExercisedAge
Mr. Omar S. IshrakChairman and Chief Exec. Officer7.71M13.56M61
Mr. Bradley E. LermanSr. VP, Gen. Counsel and Corp. Sec.1.97MN/A60
Mr. Michael J. CoyleExec. VP and Group Pres of Cardiac & Vascular Group2.56MN/A55
Mr. Bryan C. HansonExec. VP and Group Pres of Minimally Invasive Therapies Group1.76MN/A50
Mr. Gary L. EllisConsultant2.91MN/A61
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Corporate Governance

Medtronic plc’s ISS Governance QualityScore as of May 1, 2017 is 4. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 7; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.